Related Experiment Video
Updated: Jun 7, 2026
07:33
A Mouse Model of Intestinal Partial Obstruction
Published on: March 5, 2018
[Chronic intestinal pseudo-obstruction in systemic lupus erythematosus]
N Ghannouchi Jaafoura1, M Khalifa, A Atig
1Service de médecine interne et des maladies infectieuses, CHU Farhat Hached, Sousse, Tunisia. neirouz.ghannouchi@rns.tn
La Revue De Medecine Interne
|November 2, 2010
Summary
Systemic lupus erythematosus (SLE) can cause intestinal pseudo-obstruction (IPO), a severe complication. Early diagnosis and immunosuppressive treatment are crucial for managing SLE-related IPO and avoiding surgery.
Area of Science:
- Gastroenterology
- Rheumatology
- Internal Medicine
Background:
- Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with diverse clinical manifestations.
- Intestinal pseudo-obstruction (IPO) is a rare but serious gastrointestinal complication associated with SLE.
- Understanding IPO in SLE is vital for timely diagnosis and management.
Observation:
- A 24-year-old female with a 2-year history of SLE presented with acute abdominal symptoms including pain, vomiting, constipation, and distention.
- Radiographic and CT imaging revealed dilated small bowel loops consistent with IPO, alongside urinary tract involvement.
- The patient's symptoms improved significantly with immunosuppressive therapy.
Findings:
- IPO can be a presenting or concurrent manifestation of SLE.
- Abdominal imaging is key in diagnosing IPO by showing signs of obstruction without a mechanical cause.
- Urinary tract involvement can co-occur with IPO in SLE patients.
Implications:
- Early recognition of IPO in SLE patients is essential to guide appropriate treatment strategies.
- Prompt immunosuppressive treatment can effectively manage IPO symptoms and prevent complications.
- Avoiding unnecessary surgical interventions is a key benefit of accurate IPO diagnosis in SLE.
Related Concept Videos
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:07Intestinal Obstruction II: Pathophysiology
Intestinal obstruction triggers a series of physiological responses, starting with gas and fluid accumulation in the bowel segment proximal to the obstruction, leading to distension. This distended intestine compresses the diaphragm, hindering lung expansion and potentially leading to reduced respiratory effort, atelectasis, and pneumonia.To overcome the blockage, the gut intensifies contractions, causing colicky abdominal pain, nausea, and vomiting, which reduces fluid and food intake and...
01:29Intestinal Obstruction I: Introduction
Intestinal obstruction is a partial or complete blockage of the small or large intestine that disrupts the normal flow of intestinal contents through the lumen. This interruption impairs digestion, absorption, and fluid balance, and may lead to serious complications if not treated promptly.Mechanical ObstructionMechanical obstruction occurs when a physical blockage prevents intestinal contents from passing, arising from within the lumen or the bowel wall, or from external compression.Adhesions,...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:20Inflammatory Bowel Disease IV: Clinical Manifestations
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...